Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma?

Cancer Genetics and Cytogenetics

Volumn 140, Issue 2, 2003, Pages 133-137

  Stallings, R L ^a,b   Howard, J ^a   Dunlop, A ^a   Mullarkey, M ^a   McDermott, M ^a   Breatnach, F ^a   O'Meara, A ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL; CANCER STAGING; CANCER TISSUE; CHILD; CHROMOSOME 11P; CHROMOSOME 7Q; CHROMOSOME ABERRATION; CHROMOSOME G BAND; CHROMOSOME GAIN; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION 3; CHROMOSOME TRANSLOCATION 7; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; INFANT; METASTASIS; NEUROBLASTOMA; PRIORITY JOURNAL;

ABDOMINAL NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 7; GENE AMPLIFICATION; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEUROBLASTOMA; NUCLEIC ACID HYBRIDIZATION; SEQUENCE DELETION; THORACIC NEOPLASMS;

EID: 0037438886     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00681-7     Document Type: Article

References (19)

1. Brodeur G.M., Maris J.M., Yamashiro D.J., Hogarty M.D., White P.S. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol. 19:1997;93-101.
2. Guo C., White P.S., Weiss M.J., Hogaerty M.D., Thompson P.M., Stram D.O., Gerbing R., Matthay K.K., Seeger R.C., Brodeur G.M., Maris J.M. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene. 18:1999;4948-4957.
3. Vandescompele J., Van Roy N., Van Gele M., Laureys G., Ambros P., Heimann P., Devalck C., Schuuring E., Brock P., Otten J., Gyselinck J., De Paepe A., Speleman F. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer. 23:1998;141-152.
4. Vandesompele J., Speleman F., Van Roy N., Laureys G., Brinkschmidt C., Christiansen H., Lampert F., Lastowska M., Bown N., Pearson A., Nicholson J.C., Ross F., Combaret V., Delattre O., Feuerstein B.G., Plantaz D. Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors. how many genetic subgroups are there? Med Pediatr Oncol. 36:2001;5-10.
5. Plantaz D., Vandesompele J., Van Roy N., Lastowska M., Bown N., Combaret V., Favrot M.C., Delattre O., Michon J., Benard J., Hartmann O., Nicholoson J.C., Ross F.M., Brinkschmidt C., Laureys G., Caron H., Matthay K.K., Feuerstein B.G., Speleman F. Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification. Int J Cancer. 91:2001;680-686.
6. Breen C.J., O'Meara A., McDermott M., Mullarkey M., Stallings R.L. Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet. 120:2000;44-49.
7. Luttikhuis M., Powell J.E., Rees S.A., Genus T., Chughtai S., Ramani P., Mann J.R., McConville C.M. Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumors with adverse prognosis. Brit J Cancer. 85:2001;531-537.
8. Lastowska M., Nacheva E., McGuckin A., Curtis A., Grace C., Pearson A., Bown N. Comparative genomic hybridization study of primary neuroblastoma tumors. Genes Chromosomes Cancer. 18:1997;162-169.
9. Brinkschmidt C., Chistiansen H., Terpe H.J., Simon R., Boecker W., Lampert F., Stoerkel S. Comparative genomic hybridization (CGH) analysis of neuroblastomas - an important methodological approach in paediatric tumor pathology. J Pathol. 181:1997;394-400.
10. Lastowska M., Cotterill S., Pearson A.D.J., Roberts P., McGuckin A., Lewis I., Bown N. Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. Eur J Cancer. 33:1997;1627-1633.
11. Bown N., Cotterill S., Lastowska M., O'Neill S., Pearson A.D., Plantaz D., Meddeb M., Danglot G., Brinkschmidt C., Christiansen H., Laureys G., Speleman F. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med. 340:1999;1954-1961.
12. Donti E., Longo L., Tonini G.P., Verdona G., Melodia A., Lanino E., Cornaglia-Ferraris P. Cytogenetic and molecular study of two human neuroblastoma cell lines. Cancer Genet Cytogenet. 30:1988;225-231.
13. McRobert T.L., Rudduck C., Kees U.R., Garson O.M. Detection of MYCN amplification in three neuroblastoma cell lines by non-radioactive chromosomal in situ hybridization. Cancer Genet Cytogenet. 59:1992;128-134.
14. Meddeb M., Danglot G., Chudoba I., Venuat A.M., Benard J., Avet-Loiseau H., Vasseur B., Paslier D., Terrier-Lacombe M.J., Hartman O., Bernheim A. Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high grade neuroblastoma. Genes Chromosomes Cancer. 17:1996;156-165.
15. Van Roy N., Laureys G., Cheng N.C., Willem P., Opdenakker G., Versteeg R., Spelman F. 1:17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer. 10:1994;103-114.
16. Gilbert F., Feder M., Balaban G., Brangman D., Lurie D.K., Podolsky R., Rinaldt V., Vinikoor N., Weisband J. Human neuroblastoma and abnormalities of chromosomes 1 and 17. Cancer Res. 44:1984;5444-5449.
17. Joshi V.V. Peripheral neuroblastic tumors. pathologic classification based on recommendations of the international neuroblastoma pathology committee (modification of Shimada classification) Pediatr Dev Pathol. 3:2000;184-199.
18. Breen C.J., Barton L., Carey A., Dunlop A., Glancy M., Hall K., Hegarty A.M., Khokhar M.T., Power M., Ryan K., Green A.J., Stallings R.L. Applications of comparative genomic hybridization in constitutional chromosome studies. J Med Genet. 36:1999;511-517.
19. Janoueix-Lerosey I., Penther D., Thioux M., de Cremoux P., Derre J., Ambros P., Vielh P., Benard J., Aurias A., Delattre O. Molecular analysis of chromosome arm 17q gain in neuroblastoma. Genes. Chromosomes Cancer. 28:2000;276-284.